biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by lovetheoilpatchon May 13, 2015 1:03am

112 Views

Post# 23722567

RE:RE:Preaching to the choir

and maybe just maybe wed can get more volume than the zero we got again today on our stock on the highly touted grey market we are listed on in the states lol.....god can u imagine what would happen tomorrow if we were promoted by goldman or jp morgan? ...on the nyse or nsd???....this news in thusa is ground shaking.....here in Canada its just plain nothing

Bullboard Posts

Southern Ontario mineral processing operation receives green fund support